All News about Silence Therapeutics Plc ADR![]()
Silence Therapeutics to Buyback siRNA Complement Assets
March 28, 2023
Via Business Wire
![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() Via Business Wire
![]() ![]() From Silence Therapeutics
Via Business Wire
![]() ![]() ![]()
Silence Therapeutics Reports Third Quarter 2022 Results
November 10, 2022
Via Business Wire
![]() Via Business Wire
![]() ![]() ![]() ![]()
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via Benzinga
![]()
Silence Therapeutics Gets FDA Fast Track Status For Blood Cancer Candidate
September 08, 2022
Via Benzinga
![]()
Silence Therapeutics to Participate in September Investment Conferences
September 08, 2022
Via Business Wire
![]() ![]() ![]()
Silence Therapeutics Announces Pricing of Underwritten Offering
August 11, 2022
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() Via Business Wire
![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|